The LUNG RX brand, founded in 1998 (United States), from 16 sister brands and 2214 competing brands. LUNG RX is owned by United Therapeutics Co., listed on the stock exchange of New York LUNG RX is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
United Therapeutics Co.
(LUNG RX)
over 5 years*
USD 549.18